Sung Lee, MD
Clinical Cardiac Electrophysiology · Takoma Park, MDNPI 1679535983
Payments from drug & device makers
Across 364 payments — averaging $1439.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$208K
- Medtronic$204K
- Biosense Webster, Inc.$100K
- Boston Scientific$7K
- Abbott$3K
- Atricure, Inc.$421
- plus $2K from 24 others
Across 1 payment — averaging $3500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$4K
What the payments were for
- Consulting fees$18,87528%
- Speaking & faculty fees$22,70034%
- Travel & lodging$13,95121%
- Food & beverage$10,67116%
- Education$1,5002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 46 | $207,598 |
| Medtronic(2 entities) | 130 | $204,401 |
| Biosense Webster, Inc. | 67 | $100,118 |
| Boston Scientific | 17 | $6,792 |
| Abbott | 13 | $2,699 |
| Atricure, Inc. | 5 | $421 |
| Johnson & Johnson | 14 | $234 |
| Novo Nordisk | 11 | $230 |
| Novartis | 10 | $219 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $155 |
| Pfizer | 7 | $144 |
| Amgen | 1 | $131 |
| Philips North America LLC | 6 | $124 |
| Kestra Medical Technology Services, Inc. | 1 | $106 |
| Gilead | 1 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $82 |
| Irhythm Technologies, Inc. | 4 | $76 |
| Actelion Pharmaceuticals US, Inc. | 3 | $72 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Baxter Healthcare | 1 | $43 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $35 |
| Abiomed | 1 | $32 |
| Angiodynamics, Inc. | 1 | $25 |
| Merck | 1 | $24 |
| Catheter Precision Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $22 |
| Elutia, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$17,383
- Arctic Front$10,731
- DiamondTemp$1,579
- Assurity Pacemaker$1,500
- VersaCross Access Solution$1,400
- AVEIR$399
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$308
- PulseSelect$298
- COBALT DR MRI SURESCAN$289
- NA$268
- CLINICAL TRIAL PRODUCT$180
- TYRX$163
- FARAWAVE$162
- Agilis NxT EP Introducer$158
- Emboshield NAV6 system$158
- STEALTHSTATION S8 PLATFORM$150
- ENSITE$130
- Watchman$125
- Confidense$109
- Assure WCD$106
How this compares
$524,035 in reported general payments places this provider in the 95th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $72,814 |
| XareltoRivaroxaban | 17 | $22,563 |
| MultaqDronedarone Hcl | 11 | $16,211 |
| Flecainide Acetate | 33 | $849 |
| Metoprolol Succinate | 41 | $808 |
| Amiodarone Hcl | 19 | $373 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $307 |
| Losartan Potassium | 13 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $144 | $72,81454 claims |
| Johnson & JohnsonXarelto | $234 | $22,56317 claims |
| Sanofi-aventis U.S. LLCMultaq | $44 | $16,21111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
Other clinical cardiac electrophysiology in Takoma Park
- Hugh CalkinsBaltimore$2.2M
- Sean BeinartRockville$657K
- Charles LoveBaltimore$311K
- Jonathan ChrispinBaltimore$213K
- Nilofar IslamTowson$197K
- Ronald BergerBaltimore$194K
- Mukta SrivastavaBaltimore$154K
- Glenn MeiningerBaltimore$133K
- Stephen KeimSalisbury$107K
- Paresh ShahBaltimore$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.